| Stage | AMGN | % of rev | EXEL | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $10.4B | 100.00% | $629M | 100.00% | AMGN ×16.49 |
| Gross profit | $7.6B | 73.10% | $608M | 96.71% | EXEL +23.6pp |
| Operating income | $3.7B | 35.79% | $248M | 39.51% | EXEL +3.7pp |
| Pre-tax income | $4.7B | 45.21% | $263M | 41.78% | AMGN +3.4pp |
| Net income | $3.9B | 37.28% | $212M | 33.73% | AMGN +3.6pp |
| Stage | AMGN | EXEL | Gap · A − B |
|---|---|---|---|
| Revenue | $10.4B100.00% | $629M100.00% | AMGN ×16.49 |
| Gross profit | 73.10%$7.6B | 96.71%$608M | EXEL +23.6pp |
| Operating income | 35.79%$3.7B | 39.51%$248M | EXEL +3.7pp |
| Pre-tax income | 45.21%$4.7B | 41.78%$263M | AMGN +3.4pp |
| Net income |
| 37.28%$3.9B |
| 33.73%$212M |
| AMGN +3.6pp |
No shared counterparties.